These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33053805)

  • 1. Chiral Cyclobutane-Containing Cell-Penetrating Peptides as Selective Vectors for Anti-
    Illa O; Olivares JA; Gaztelumendi N; Martínez-Castro L; Ospina J; Abengozar MÁ; Sciortino G; Maréchal JD; Nogués C; Royo M; Rivas L; Ortuño RM
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid Cyclobutane/Proline-Containing Peptidomimetics: The Conformational Constraint Influences Their Cell-Penetration Ability.
    Illa O; Ospina J; Sánchez-Aparicio JE; Pulido X; Abengozar MÁ; Gaztelumendi N; Carbajo D; Nogués C; Rivas L; Maréchal JD; Royo M; Ortuño RM
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Searching for new cell-penetrating agents: hybrid cyclobutane-proline γ,γ-peptides.
    Gorrea E; Carbajo D; Gutiérrez-Abad R; Illa O; Branchadell V; Royo M; Ortuño RM
    Org Biomol Chem; 2012 May; 10(20):4050-7. PubMed ID: 22514076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
    Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
    Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma.
    Dragojevic S; Mackey R; Raucher D
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31489879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2.
    Xiang Y; Shan W; Huang Y
    Int J Pharm; 2018 Nov; 551(1-2):14-22. PubMed ID: 30205127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis.
    Lyu L; Huang LQ; Huang T; Xiang W; Yuan JD; Zhang CH
    Drug Des Devel Ther; 2018; 12():743-756. PubMed ID: 29670331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Cell-Penetrating Peptide (KRP) with Multiple Physicochemical Properties Endows Doxorubicin with Tumor Targeting and Improves Its Therapeutic Index.
    Yu M; Li X; Huang X; Zhang J; Zhang Y; Wang H
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):2448-2458. PubMed ID: 30576099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy.
    Mansur AAP; Carvalho SM; Lobato ZIP; Leite MF; Cunha ADS; Mansur HS
    Bioconjug Chem; 2018 Jun; 29(6):1973-2000. PubMed ID: 29790738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structural study of highly constrained hybrid cyclobutane-proline γ,γ-peptides.
    Gutiérrez-Abad R; Carbajo D; Nolis P; Acosta-Silva C; Cobos JA; Illa O; Royo M; Ortuño RM
    Amino Acids; 2011 Aug; 41(3):673-86. PubMed ID: 21541681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative.
    Walker L; Perkins E; Kratz F; Raucher D
    Int J Pharm; 2012 Oct; 436(1-2):825-32. PubMed ID: 22850291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
    Young Kim H; Young Yum S; Jang G; Ahn DR
    Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
    Kanwar JR; Gibbons J; Verma AK; Kanwar RK
    Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
    Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
    J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability.
    Zhang S; Liu Y; Gan Y; Qiu N; Gu Y; Zhu H
    Pharm Dev Technol; 2019 Feb; 24(2):253-261. PubMed ID: 29688120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.
    Lelle M; Frick SU; Steinbrink K; Peneva K
    J Pept Sci; 2014 May; 20(5):323-33. PubMed ID: 24677287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide.
    Moon C; Kwon YM; Lee WK; Park YJ; Yang VC
    J Control Release; 2007 Dec; 124(1-2):43-50. PubMed ID: 17904680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell penetration and cell-selective drug delivery using α-helix peptides conjugated with gold nanoparticles.
    Park H; Tsutsumi H; Mihara H
    Biomaterials; 2013 Jul; 34(20):4872-9. PubMed ID: 23545289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second generation, arginine-rich (R-X'-R)(4)-type cell-penetrating α-ω-α-peptides with constrained, chiral ω-amino acids (X') for enhanced cargo delivery into cells.
    Patil KM; Naik RJ; Vij M; Yadav AK; Kumar VA; Ganguli M; Fernandes M
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4198-202. PubMed ID: 25096299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.